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Human platelets prelabeled wtth [3H]mosttol were exposed to thrombm The aqueous soluble mosttol phos- 
phates were separated by amon exchange column chromatography, paper chromatography or high-per- 
formance hqutd chromatography, and ldentl~ed by c~hromatography wtth authentic standard substances 
Thrombm tmmedtately mduces the raped formatton of mosrtol 1,4-btsphosphate and mosttol 1,4,5-trt- 
sphosphate Accumulation of mosttol-1-monophosphate and mositol-2-monophosphate occurs later after 
a time lag of 10 set The results mdtcate that the phosphohpase C Induced polyphosphomosrttde hydrolyses 
rather than the phosphatldyllnosltol hydrolyses is the tnggermg event for platelet actrvatron, and support 
the concept of mosttol I ,4,Stnsphosphate as putattve second messenger 
Piatelet actzvatzon Thrombzn Phospholzpase C Znosztolphosphate Znosztol phospholzpzd 
1. INTRODUCTION 
Physlologic~ platelet strmuh such as thrombin, 
collagen, ADP, platelet-activating factor, arachr- 
donic acid and prostaglandin endoperoxides in- 
duce m platelets the degradation of inositol con- 
taining phospholipids [l-6]. This reaction, which 
is catalysed by phospholipase C, leads to two 
putative second messengers: mositol 1,4,5-tris- 
phosphate, which can mobihse Ca2+ from non- 
mltochondrlal pools, and 1,2-diacylgly~erol, which 
stimulates protein phosphorylation by protem 
kinase C activation [7-91. Both molecules have 
been found in stimulated platelets, and they may 
act synergistically to induce the physlologic~ 
platelet response [2,10,11]. Recently, we have 
shown the close associatton of phospholipase C ac- 
tivation with each physiological platelet response, 
i.e., platelet shape change, release reaction and ag- 
gregation [5,6,12-151. It is not clear which of the 
Abbrevzatzons: PtdIns, phosphatldyllnosltol; PtdIns4P, 
phosphat~dyllnositol 4-phosphate; PtdIns4,5Pz, phos- 
phattdylinositol 4,S-bisphosphate; HPLC, high-perfor- 
mance liquid chromatography 
three inositol phospholipids - PtdIns, PtdIns4P or 
PtdIns4,5Pz - is degraded initially by phos- 
pholipase C upon receptor activation [ 161. Follow- 
ing recent studies on platelets and other cell types 
it seems that PtdIns4JPz rather than PI is 
hydrolysed ([10,17-191; for review see [7]). To ad- 
dress this question further, we measured the for- 
mation of the respective inositol phosphates m 
human platelets upon activation with thrombin. 
2. MATERIALS AND METHODS 
2.1. Materials 
L-myo[2-3H]inositol was purchased from NEN, 
and L-3-phosphatidyl[U-14C]inositol and L- 
myo[U-‘4CJinositol-l-phosphate were from Amer- 
sham. L-cY-phosphatidylinositol, L-cu-phosphati- 
dylinositol 4-monophosphate, Lti-phosphatidyl- 
inositol4,5-bisphosphate, phosphoinositides, L-cu- 
glycerophosphate, Dowex 1 x 8 (chloride form 
100-200 mesh), Dowex-HCR-W2, myoinositol 
2-monophosphate and phospholipase C from 
Bacillus cereus were all obtained from Sigma. 
Equipment and columns for HPLC were from 
Waters. 
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2.2. Preparation of mositol phosphate standards 
The alkaline hydrolysis of phosphomositides as 
described by Grado and Ballou [20] leads to a mix- 
ture of two isomers of inosrtol trisphosphate and 
of inositol bisphosphate which are separated by 
descending paper chromatography [21]. By com- 
parison with the work of Ballou and colleagues 
[20,22] and Irvine et al. [23], these compounds are 
identified as inositol 1,4,5trisphosphate (slow- 
running), mositol 2,4,5trisphosphate (fast- 
running), inositol 1 ,Cbrsphosphate (slow-running) 
and inosrtol 4,5-bisphosphate (fast-running). In- 
osrtol 1,4,5trrsphosphate and mositol 1 ,Cbisphos- 
phate were also obtained by alkaline hydrolysis of 
authentic PtdIns4,5P2 and PtdIns4P. Glycero- 
phosphoinositol was prepared by mild alkaline 
hydrolysis from phosphatidylinosrtol [24]. Inositol 
1,2-cyclic monophosphate was obtained by incuba- 
tion of phosphatidylinositol with phospholipase C 
from platelet cytosol or from B. cereus [25,26]. 
Inositol 1-monophosphate and inositol-2-mono- 
phosphate were obtained by heating inositol 1,2- 
cychc monophosphate at 100°C for 15 min in 
0.1 N HCl [27]. 
2.3. Preparation of platelets labeled with 
PHjinositol 
Platelet rich plasma was prepared from human 
blood (100 ml) anticoagulated with acidic 
citrate/dextrose [ 121. Prostacyclin (300 ng/ml) 
was added, platelets were centrifuged and 
resuspended in Tyrode-Hepes buffer [12] at a 
platelet concentration of 2-2.5 x 109/ml. [3H]In- 
ositol(1 mCi) and MnCl2 (3 mM) were added, and 
platelet suspensions were incubated m ag- 
gregometer tubes at 37°C for 90 min while stirring 
(250 rpm). PGEr (1 fig/ml) and EGTA (5 mM) 
were added, and after further 30 min of incubation 
the platelets were centrifuged and washed once m 
Tyrode-Hepes buffer containing 5 mM unlabeled 
inositol, 1 mM EGTA, 10% of plasma and pro- 
stacyclin (300 ng/ml). Platelets were finally 
resuspended in lo-12 ml of Tyrode-Hepes buffer 
containing 1 mM EGTA. 
Samples of platelet suspensions (0.5 ml) were 
placed in aggregometer tubes, LiCl (10 mM) was 
added, and platelets were stirred for 2 mm before 
exposure to thrombin (2 U/ml). Shape change and 
aggregation were recorded. Reactions were 
stopped by transferring the samples into 1.8 ml of 
108 
chloroform/methanol, 1: 2. Since endogenously 
formed mositol phosphates including inositol 
trtsphosphate were recovered at the same rate 
following extraction at acidic or neutral pH, 
aqueous soluble inositol phosphates were extracted 
at neutral pH [28] in order to avoid degradation of 
mositol 1,2-cyclic monophosphate [27]. The 
samples were then frozen, lyophilised and stored at 
- 20°C. 
2.4. Separation of rnosltol phosphates 
Amon exchange column chromatography on 
Dowex 1 x 8 columns (1 ml) was used as first step 
to separate the inosttol phosphates. Dowex in 
chloride form was converted mto the formate form 
with 8 ml of 5% formic acid and rinsed with 25 ml 
of H20. The lyophihsed platelet samples were 
dissolved in 1 ml of Hz0 and a mixture of un- 
labeled inosttol phosphate standards (inosnol 
1,4,5_trisphosphate, inositol 1,4-brsphosphate, 
glycerophosphoinosttol, mositol l-phosphate, m- 
ositol2-phosphate) was added. If the samples were 
separated subsequently on HPLC, two fractions 
were eluted: Inositol and some glycerophospho- 
mositol in 30 ml of Hz0 and mosrtol phosphates m 
14 ml of 1 M ammonium formate, 100 mM formic 
acid. If the samples were separated subsequently 
by paper chromatography, the following fractions 
were eluted [29]: fraction I (30 ml of H20); frac- 
tion II containing mosrtol monophosphates (20 ml 
of 200 mM ammonium formate, 100 mM formic 
acid); fraction III containing inositol bisphosphate 
(20 ml of 400 mM ammonium formate, 100 mM 
formic acid); fraction IV containing inosrtol 
trisphosphate (12 ml of 1 M ammonium formate, 
100 mM formic acid). In order to remove the am- 
monium ions the eluates were passed through 
Dowex HCR-W2 columns (10 ml) followed by 
rinsing with 50 ml of H20. The eluates were then 
dried at 40°C by rotoevaporation ex vacua and 
further separated either by descending paper 
chromatography [20,21] or by HPLC. Separation 
by HPLC was carried out on a pBondapak 
NHz-column (3.9 mm x 30 cm) utilising a 20 min 
isocratic elution with 75 mM ammonium acetate/ 
acetic acid followed by a 120 min linear gradient o 
2 M ammonium acetate/acetic acid, pH 4.0, at a 
flow rate of 1 ml/min. Fractions were collected, 
split into two halves and either measured for 3H- 
radioactivity by liquid scintillation counting or for 
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phosphorus [30]. Inosttol phosphates in samples 
separated by paper chromatography were visuahs- 
ed by an ammomum molybdate spray [25]. The 
respective zones were cut out, eluted with 1 ml of 
0.1 N NaOH and 1 ml of Hz0 and measured for 
3H-radioactivity by liquid scintrllatron counting. 
2.5. Separatron of mosltol phospholrplds 
Inositol phospholiplds were extracted at acidic 
pH [19] and separated on thm layer plates im- 
pregnated with 1% potassmm oxalate [31]. 
3. RESULTS AND DISCUSSION 
The addition of thrombin to human platelets 
prelabeled with [3H]inositol induces the formation 
of four radioactive inositol phosphates: inositol 
1-monophosphate, mosrtol 2-monophosphate, m- 
ositol 1,4-bisphosphate and inositol 1,4,5tris- 
phosphate. These products were identified by 
cochromatography with authentic standards on 
HPLC or paper chromatography (fig.l,2). Both 
HPLC and paper chromatography separated 
isomers of inositol mono-, brs- and trisphosphate. 
Since the radioactive inositol phosphates formed in 
stimulated platelets cochromatographed with 
authentic standards in both chromatographic 
systems, it 1s evident that the formed inosrtol 
phosphates have the structures indicated above. 
One has to be aware, however, that the identifica- 
tion of any structure which IS based solely on 
cochromatography of radioactivity with authentic 
compounds is not absolute [32]. 
We observed that for the measurement of the 
various mosrtol phosphates one could not rely on 
the Dowex anion exchange column chromatog- 
raphy, since a small percentage of the bulk of 
[3H]inositol is eluted m the inositol monophos- 
phate fraction (see also fig.la), and more impor- 
tantly, between 10 and 25% of the inositol bis- 
phosphate is eluted in the inositol trisphosphate 
fraction (unpublished). Since the amount of the 
radioactive mositol bisphosphate formed is high if 
compared to the amount of inositol trisphosphate, 
the use of the Dowex column chromatography 
would lead to false high levels for inositol trisphos- 
phate. We therefore used the Dowex column chro- 
matography only as first purification step of in- 
ositol phosphates before their final separation by 
HPLC or paper chromatography. Recovery of 
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Fig 1. HPLC-separation of mositol phosphates formed 
m human platelets after exposure to thrombin. Human 
platelets were prelabeled wtth [3H]mositol and etther 
sahne (a) or thrombm (2 U/ml) was added for 10 s (b) 
or 5 mm (c). The aqueous soluble [3H]mositol 
phosphates (M) were extracted, a mrxture of 
unlabeled mosrtol phosphate standards (A---A) was 
added, and the samples were purrfred on Dowex column 
chromatography before separatron on HPLC. For 
further detads see section 2. 
unlabeled inosrtol phosphate standards after 
Dowex column chromatography and HPLC was 
76 + 15010 for inositol-1,4,5_trisphosphate, 66 f 
15% for inositol 1,6bisphosphate, 69 f 9% for in- 
ositol 1-monophosphate and 72 + 8% for inositol 
2-monophosphate (mean -t SD, n = 8). 
The formation of inositol bisphosphate and in- 
ositol trisphosphate can be detected 5 s after addi- 
tion of thrombm (fig.3). Inositol trisphosphate 
reaches rts peak level at 10 s, whereas inositol 
brsphosphate accumulates further. In contrast, in- 
creased formation of both inositol l-monophos- 
phate and inosltol 2-monophosphate is not detect- 
able until 10 s after addition of thrombin. After 
109 
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Ftg 2. Formatton of mosnol i,4,5-trisphosphate m 
standard substances (upper panel) 
human platelets after exposure to thrombm Human 
platefets were prelabeled wnh [3~]lnosItol, and enher 
sahne (A---A) or thrombm (2 U/ml; o-----e) was added 
for 10 s, A mtxture of mosrtol phosphates produced by 
alkaline hydrolysis of phospho~nos~tldes [ZO] was added, 
pools of 5 samples were extracted and subjected to 
subsequent Dowex column chromatography [29] and 
descendmg paper chromatography [21]. The ftgure 
shows a radroactrve profde on descending paper 
chromatography of the Dowex-fractron contarmng 
mos1tol trisphosphate (lower panel) and the 
cochromatography wtth unlabeled mosttoi tr~sphosphat~ 
that time lag inosrtol I-monophosphate and m- 
o&d 2-mono~hos~~ate show a co~tl~~o~s, large 
acc~m~~ati~n (fig.3, t&k I), The formation of in- 
ositoi Z-monophosphate m addition to mositof 
Fig 3. Trme-course of mosttot phosphate formatron m 
human platelets after add&ton of thrombm Human 
tography and HPLC as shown m fig I. 
platelets were prelabeled wrth r~~~lnos~tol Incorpora- 
tion of ‘H mto phosphoinositldes of 0.9 ml platelet sus- 
penston was 92691 cpm for PtdIns, 18835 cpm for 
PtdKns4P and 4490 cpm for PtdIns4,5Pz. Platelet 
suspensions were strmulated wrth thrombm (2 U/ml) for 
vartous times, a mrxture of unlabeled inosrtol phosphate 
standards was added and 3H-labeied mositoi phosphates 
were separated by subsequent Dowex column chroma- 
I-monophosphate could reflect the tranaent for- 
mation of mositof t,2-cyclic-mo~op~osphate [27]. 
Similar trme courses of mos~tol phosphate forma- 
tlon upon specrfic cell activation have been 
Table 1 
Thromb~n-~~du~~ formatton of mosttol phosphates m human platelets 
Additrons 3H-Radroactrvtty &pm) 
Ins Pi Ins 1,4-Pz Ins 1,4,5-P3 
None 305 + 78 24-+. 13 1+ 2 
Thrombm, 10 s 301 zt 63 461 + 206 5.5 4 27 
Thromb~n* 5 mm 6117 f 1953 1653 t 299 44 + 22 
Platelets prelabeied wrth 13Hfmosrtul were exposed to thrombm (2 U/ml). InosrtoI 
phosphates were separated by subsequent anion exchange cotumn chromatography 
and paper chromatography (see section 2) Values are mean + SD of 5 experiments 
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reported for other cell types prelabeled with 
[3H]inositol ([33,34]; for ref. see [7]). 
The results indicate polyphosphoinositide 
hydrolysis, but also provide evidence for PtdIns 
hydrolysis m stimulated platelets. If the rate of 
conversron of labeled inositol phosphohpids to the 
corresponding inositol phosphates 5 min after ad- 
drtion of thrombm (2 U/ml) IS calculated, there IS 
a conversion rate of 1.5 + 0.6% for PtdIns4,5Pz, 
of 20 + 8% for PtdIns4P and of 10 + 3% for 
PtdIns (mean f SD from 3 experrments). This may 
indicate that there is only a small pool of radioac- 
tive PtdIns4JP2 - if compared to PtdIns4P and 
Ptdlns - which is degraded by phospholipase C. 
These results, however, do not exclude the 
pathway proposed recently by which Ptdlns is 
refueling PtdIns4P and PtdIns4,5Pz, which is then 
hydrolysed to inositol trisphosphate and degraded 
to mositol bisphosphate and monophosphate 
[7,18,29,33]. 
The rapid formatton of inositol 1,4-bisphos- 
phate and mositol 1,4,5trisphosphate in stimu- 
lated platelets indicates that PtdIns4P and 
PtdIns4,5P2 are hydrolysed before PtdIns by 
phospholipase C. From the present results it seems 
that both PtdIns4P and PtdIns4,5P2 are degraded 
initially following platelet exposure to thrombm. 
The rapid, but restricted formation of the potent 
Ca’+-mobiliser inositol 1,4,5trisphosphate may 
indicate that the enzymatic hydrolyses of 
PtdIns4,5P2 IS tightly controlled. Another possible 
regulation step could be the actrvation of a specific 
phosphomonoesterase which degrades mositol 
1,4,5_trisphosphate to inositol 1,6bisphosphate 
[35]. The study of the enzymatic regulation of the 
formation and inactivation of inositol 1,4,5-tris- 
phosphate may give further Insights into the 
mechanism of platelet activation. 
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